Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Tagliani

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Mbio|August 31, 2017
The New Xpert MTB/RIF Ultra: Improving Detection of <i>Mycobacterium tuberculosis</i> and Resistance to Rifampin in an Assay Suitable for Point-of-Care TestingSoumitesh Chakravorty, Ann Marie Simmons, Mazhgan Rowneki, et al.
BMC Infectious Diseases|August 15, 2024
Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial)Chacha Mangu, Marta Cossa, Robert Ndege, et al.
The Lancet. Infectious Diseases|May 9, 2026
Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trialMarta Cossa, Robert Ndege, Bindiya Meggi, et al.
The European Respiratory Journal|December 30, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in <i>Mycobacterium tuberculosis</i>Paolo Miotto, Belay Tessema, Elisa Tagliani, et al.
Nature Reviews. Microbiology|June 19, 2019
Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issuesConor J Meehan, Galo A Goig, Thomas A Kohl, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Mbio|August 31, 2017
The New Xpert MTB/RIF Ultra: Improving Detection of <i>Mycobacterium tuberculosis</i> and Resistance to Rifampin in an Assay Suitable for Point-of-Care TestingSoumitesh Chakravorty, Ann Marie Simmons, Mazhgan Rowneki, et al.
BMC Infectious Diseases|August 15, 2024
Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial)Chacha Mangu, Marta Cossa, Robert Ndege, et al.
The Lancet. Infectious Diseases|May 9, 2026
Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trialMarta Cossa, Robert Ndege, Bindiya Meggi, et al.
The European Respiratory Journal|December 30, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in <i>Mycobacterium tuberculosis</i>Paolo Miotto, Belay Tessema, Elisa Tagliani, et al.
Nature Reviews. Microbiology|June 19, 2019
Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issuesConor J Meehan, Galo A Goig, Thomas A Kohl, et al.
Pageof 4